Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Circulation|March 17, 1999
Pulmonary embolism: one-year follow-up with echocardiography doppler and five-year survival analysisA Ribeiro, P Lindmarker, H Johnsson, et al.Thrombosis and Haemostasis|June 12, 1999
The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of AnticoagulationP Lindmarker, S Schulman, M Sten-Linder, et al.Journal of Thrombosis and Haemostasis : JTH|January 18, 2006
Evaluation of low PAI-1 activity as a risk factor for hemorrhagic diathesisA Agren, B Wiman, V Stiller, et al.The New England Journal of Medicine|June 22, 1995
A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study GroupS Schulman, A S Rhedin, P Lindmarker, et al.The New England Journal of Medicine|February 6, 1997
The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study GroupS Schulman, S Granqvist, M Holmström, et al.Journal of Thrombosis and Haemostasis : JTH|April 26, 2006
Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 monthsS Schulman, P Lindmarker, M Holmström, et al.Pageof 2